Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
AVGO closed the week at $375.81, up nearly 6% on the week, yet the Street's mean price target of $531 implies the stock still trades at a 41% discount to consensus. That gap is the central tension heading into December earnings.
The lending market offers no friction for either side of the trade. Short interest has ticked up fractionally, about 0.7% on the week, but remains just 1.1% of the free float, a level too low to drive any meaningful narrative. Borrow costs are equally benign at 0.29%, though they have risen 21% over the past week and 64% over the past month from an extremely low base. Availability is essentially unlimited, showing no constraint whatsoever in the lending pool. The options market confirms the lack of urgency: the put/call ratio is almost exactly in line with its 20-day average at 1.00, and sits well within the 52-week range of 0.89 to 1.23. There is no hedging signal worth flagging here.
The more interesting story is what the Street did immediately after Broadcom's last earnings print on September 3. The reaction was a sell-the-news episode, with the stock falling around 3.4% on the day and another 1.4% over the following week. Yet analysts responded with a split verdict. Citigroup raised its target to $515 and kept its Buy. Raymond James lifted its target to $475. Morgan Stanley nudged its Overweight target up to $505 from $502. On the other side, TD Cowen and Truist both maintained positive ratings but trimmed targets, to $475 and $520 respectively, while DA Davidson cut its Neutral target sharply to $350 from $400. Macquarie upgraded to Outperform with a $490 target on the day of the print. Piper Sandler initiated coverage in September with an Overweight at $460. The overall tilt is constructive: the analyst recommendation factor ranks in the 93rd percentile of the universe. But the dispersion in targets from $350 to $578 reflects a market that has not yet resolved its view on pace and durability of the AI revenue build-out.
The bull case rests on management's guidance for AI revenue to reach $115 billion in fiscal 2027 and $230 billion in fiscal 2028, with EPS expected to exceed $30 in FY28. Customer wins at Google, Anthropic, OpenAI, and Meta underpin those numbers. The company's quality credentials are clear: an EPS momentum factor in the 60th percentile, an ORTEX short score of just 29.6 (placing it in the 85th percentile for low short pressure), and a dividend factor ranking in the 99th percentile. The trailing P/E runs at 21.4x and EV/EBITDA at 17.4x, both having drifted higher over the past month as the stock recovered. The bears point to a late-cycle semiconductor risk profile, non-AI segment misses in the last quarter, gross margin drift toward 72% as AI semis dilute the higher-margin software mix, and the longer-term risk that Google internalises ASIC design. Infrastructure software revenue also came in light in the most recent print, raising questions about the post-VMware integration cadence.
One piece of insider data worth noting: co-founder and director Henry Samueli sold roughly $89 million of stock in a cluster of transactions on September 23, all executed under a pre-arranged 10b5-1 plan. Planned sales carry less informational weight than discretionary ones, and the sales came after a period of weakness, but the net insider position over the past 90 days amounts to a net sale of around $280 million. Institutional holders show the opposite direction: BlackRock added 12.3 million shares in the most recent quarter, FMR added 20.2 million, and State Street added 5.5 million, all reported through September 30. There is no activist on the 13D register.
Retail attention has drifted lower, with Wikipedia views for AVGO running 1.75 standard deviations below the 90-day average, suggesting the name has moved out of the mainstream conversation since the summer surge. With the next earnings event set for December 10, the next 64 days are about whether AI revenue visibility tightens further or whether non-AI weakness and margin pressure begin to reassert themselves as the dominant narrative before the print.
See the live data behind this article on ORTEX.
Open AVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
